BioWorld https://www.bioworld.com/rss en-us Biopharma exec settles with SEC over misappropriation claims http://www.bioworld.com/articles/730830 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730830-biopharma-exec-settles-with-sec-over-misappropriation-claims Regulatory actions for April 30, 2026 http://www.bioworld.com/articles/730759 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730759-regulatory-actions-for-april-30-2026 Other news to note for April 30, 2026 http://www.bioworld.com/articles/730758 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730758-other-news-to-note-for-april-30-2026 In the clinic for April 30, 2026 http://www.bioworld.com/articles/730757 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730757-in-the-clinic-for-april-30-2026 Financings for April 30, 2026 http://www.bioworld.com/articles/730756 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730756-financings-for-april-30-2026 Appointments and advancements for April 30, 2026 http://www.bioworld.com/articles/730755 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730755-appointments-and-advancements-for-april-30-2026 HHS appeals federal injunction ruling on vaccine changes http://www.bioworld.com/articles/730754 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730754-hhs-appeals-federal-injunction-ruling-on-vaccine-changes Day One buyout headlines active Q1 for cancer stocks http://www.bioworld.com/articles/730753 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730753-day-one-buyout-headlines-active-q1-for-cancer-stocks Financial graph EMA launches pilot for breakthrough medical devices in the EU http://www.bioworld.com/articles/730752 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730752-ema-launches-pilot-for-breakthrough-medical-devices-in-the-eu EMA icons Axsome’s Auvelity cleared for large Alzheimer’s agitation market http://www.bioworld.com/articles/730751 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730751-axsomes-auvelity-cleared-for-large-alzheimers-agitation-market Auvelity Credit: Axsome Therapeutics Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal http://www.bioworld.com/articles/730749 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730749-beone-eyes-huahui-healths-trispecific-hh-160-with-2b-option-deal Antibodies Dermatology specialist Leo Pharma makes a $50M move into gene therapy http://www.bioworld.com/articles/730748 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730748-dermatology-specialist-leo-pharma-makes-a-50m-move-into-gene-therapy Skin anatomy and DNA Mists of Avalyn thicken with $300M IPO for inhaled drugs http://www.bioworld.com/articles/730746 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730746-mists-of-avalyn-thicken-with-300m-ipo-for-inhaled-drugs Going public ticker Unique trial strategy muddies the ODAC waters for camizestrant http://www.bioworld.com/articles/730745 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730745-unique-trial-strategy-muddies-the-odac-waters-for-camizestrant Breast anatomy Unique trial strategy muddies the ODAC waters for camizestrant http://www.bioworld.com/articles/730760 Thu, 30 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730760-unique-trial-strategy-muddies-the-odac-waters-for-camizestrant Today's news in brief http://www.bioworld.com/articles/432891 Thu, 30 Apr 2026 10:00:00 -0400 https://www.bioworld.com/articles/432891-todays-news-in-brief Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control http://www.bioworld.com/articles/730790 Thu, 30 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730790-quintuple-glp-1gipppar-agonist-for-obesity-and-diabetes-control Glucagon-like peptide-1 receptor (GLP-1R) complex Glucagon-like peptide-1 receptor (GLP-1R) complex, representing the molecular target for GLP-1 agonists. Detailed view of the binding site with small-molecule agonist. MFDS clears Curocell’s anbal-cel as first homegrown CAR T therapy Rimqarto (anbalcabtagene-autoleucel; anbal-cel) April 29 as the first homegrown CAR T-cell therapy to treat patients with advanced diffuse large B-cell lymphomas.]]> http://www.bioworld.com/articles/730685 Thu, 30 Apr 2026 08:00:00 -0400 https://www.bioworld.com/articles/730685-mfds-clears-curocells-anbal-cel-as-first-homegrown-car-t-therapy Green approved stamp Purdue sentenced in federal court, ordered to pay $5B http://www.bioworld.com/articles/730810 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730810-purdue-sentenced-in-federal-court-ordered-to-pay-5b FDA looks toward a future of continuous real-time trials http://www.bioworld.com/articles/730809 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730809-fda-looks-toward-a-future-of-continuous-real-time-trials Regulatory actions for April 29, 2026 http://www.bioworld.com/articles/730693 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730693-regulatory-actions-for-april-29-2026 Other news to note for April 29, 2026 http://www.bioworld.com/articles/730692 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730692-other-news-to-note-for-april-29-2026 In the clinic for April 29, 2026 http://www.bioworld.com/articles/730691 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730691-in-the-clinic-for-april-29-2026 Financings for April 29, 2026 http://www.bioworld.com/articles/730690 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730690-financings-for-april-29-2026 Appointments and advancements for April 29, 2026 http://www.bioworld.com/articles/730689 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730689-appointments-and-advancements-for-april-29-2026 Enterobiotix raises $25.7M for phase IIb of microbiome pill in IBS http://www.bioworld.com/articles/730688 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730688-enterobiotix-raises-257m-for-phase-iib-of-microbiome-pill-in-ibs British pound symbol Caredx to acquire Naveris for up to $260 million http://www.bioworld.com/articles/730687 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730687-caredx-to-acquire-naveris-for-up-to-260-million Cancer diagnostic illustration Bio Korea 2026 kicks off with spotlight on oligonucleotides http://www.bioworld.com/articles/730686 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730686-bio-korea-2026-kicks-off-with-spotlight-on-oligonucleotides AI generated image for researcher developing antisense oligonucleotides China’s new IIT rules could reshape early stage drug development http://www.bioworld.com/articles/730684 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730684-chinas-new-iit-rules-could-reshape-early-stage-drug-development Art concept for gene therapy research AA meeting of minds as PTC, Novartis push votoplam in HD http://www.bioworld.com/articles/730683 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730683-aa-meeting-of-minds-as-ptc-novartis-push-votoplam-in-hd Neurons